Target practice in severe asthma.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 28356505.
- Also identified by DOI 10.1126/scitranslmed.aan0769.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The NLRP3 inflammasome/caspase-1/IL-1β axis may be a therapeutic target in severe steroid-resistant asthma.
Medical subject headings
- Asthma
- Inflammasomes